Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period Through Week 240	STARTED	Tenofovir DF	141
Treatment Period Through Week 240	STARTED	FTC/Tenofovir DF	139
Treatment Period Through Week 240	COMPLETED	Tenofovir DF	121
Treatment Period Through Week 240	COMPLETED	FTC/Tenofovir DF	118
Treatment Period Through Week 240	NOT COMPLETED	Tenofovir DF	20
Treatment Period Through Week 240	NOT COMPLETED	FTC/Tenofovir DF	21
Treatment-Free Follow-up (TFFU) Period	STARTED	Tenofovir DF	38
Treatment-Free Follow-up (TFFU) Period	STARTED	FTC/Tenofovir DF	37
Treatment-Free Follow-up (TFFU) Period	COMPLETED	Tenofovir DF	12
Treatment-Free Follow-up (TFFU) Period	COMPLETED	FTC/Tenofovir DF	19
Treatment-Free Follow-up (TFFU) Period	NOT COMPLETED	Tenofovir DF	26
Treatment-Free Follow-up (TFFU) Period	NOT COMPLETED	FTC/Tenofovir DF	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00737568/flow